VISN compared with INDV: revenue, margins and what each company keeps, and the suppliers and customers both name

VISNVistance Networks, Inc.

Mkt capRevenueRevenue

INDVIndivior Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

VISNVistance Networks, Inc.

INDVIndivior Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VISN

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.6%▼−18.22%×1.90

Apr 30 '26±4.9%▲+22.21%×4.53

Q1 FY26±5.8%▲+0.16%×0.03

Feb 26 '26±6.3%▲+0.11%×0.02

INDV

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.3%▲+1.38%×0.11

Q2 FY26—▼−6.60%—

= impliedVISN realized, solidINDV realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedspan: VISN 161d · INDV 245dSource: market data

Q1 FY26

±12.8%

▲+7.70%

×0.60

Feb 26 '26±13.8%▲+0.24%×0.01

VISNVistance Networks, Inc.

6.49· pre 6.49· delayed

Mkt cap$1.5BRevenue$320MQ2 FY26Revenue—

INDVIndivior Pharmaceuticals, Inc.

36.27· pre 36.50· delayed

Pre-marketNov 2 '26delayed

Mkt cap$4.2BRevenue$356MQ3 FY26Revenue$1.2BFY25

Compare

Pre-marketNov 2 '26delayed

VISNVistance Networks, Inc.

INDVIndivior Pharmaceuticals, Inc.

6.49pre 6.49delayed

Price

36.27pre 36.50delayed

$1.5B

Mkt cap

$4.2B

Q2 FY26$320M

Revenue

$356MQ3 FY26

—

Revenue

$1.2BFY25

VISN6.49vsINDV36.27Pre-marketNov 2 '26delayed